Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable POZ lipids to replace current ionizable lipids for the ...

The development of nucleic-acid therapeutics, ranging from aptamers and antisense RNA to messenger RNA (mRNA)-based vaccines and gene therapies, is a rapidly evolving industry that has the potential ...

PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in ...

The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical grid power for AI compute and launch the "Forever Archive" for enterprise data ...

GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, today announced a strategic ...

According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 ...

When chemists design drug candidates, shape matters enormously. Many active pharmaceutical ingredients contain branched carbon structures—points where the molecular chain forks in a specific direction ...

The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized ...